Combining immunomodulators and antivirals for COVID-19 – Authors' reply

Raquel Almansa; Ana P. Tedim; Amanda de la Fuente; Jose María Eiros; David J. Kelvin; Antoni Torres; Jesus F. Bermejo-Martin

doi:10.1016/S2666-5247(21)00115-4

Combining immunomodulators and antivirals for COVID-19 – Authors' reply

Raquel Almansa, Ana P. Tedim, Amanda de la Fuente, Jose María Eiros, David J. Kelvin, Antoni Torres, Jesus F. Bermejo-Martin

Medicine

Medicine

Résultat de recherche: Letter › examen par les pairs

Langue d'origine	English
Pages (de-à)	e234
Journal	The Lancet Microbe
Volume	2
Numéro de publication	6
DOI	https://doi.org/10.1016/S2666-5247(21)00115-4
Statut de publication	Published - juin 2021

Note bibliographique

Funding Information:
JFB-M, RA, APT, JME, AT, and DJK have a patent pending (EP20383140.9). AT reports grants from Instituto de Salud Carlos III. DJK reports grants from Canadian Institutes of Health Research, Research Nova Scotia, Atlantic Genome/Genome Canada, Li-Ka Shing Foundation, and Dalhousie Medical Research Foundation. AdlF declares no competing interests.

ASJC Scopus Subject Areas

Infectious Diseases
Microbiology (medical)
Microbiology
Virology

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1016/S2666-5247(21)00115-4

Autres fichiers et liens

Citer

@article{68fd2e232aa94eb08731088da3f57331,

title = "Combining immunomodulators and antivirals for COVID-19 – Authors' reply",

author = "Raquel Almansa and Tedim, {Ana P.} and {de la Fuente}, Amanda and Eiros, {Jose Mar{\'i}a} and Kelvin, {David J.} and Antoni Torres and Bermejo-Martin, {Jesus F.}",

note = "Funding Information: JFB-M, RA, APT, JME, AT, and DJK have a patent pending (EP20383140.9). AT reports grants from Instituto de Salud Carlos III. DJK reports grants from Canadian Institutes of Health Research, Research Nova Scotia, Atlantic Genome/Genome Canada, Li-Ka Shing Foundation, and Dalhousie Medical Research Foundation. AdlF declares no competing interests.",

year = "2021",

month = jun,

doi = "10.1016/S2666-5247(21)00115-4",

language = "English",

volume = "2",

pages = "e234",

journal = "The Lancet Microbe",

issn = "2666-5247",

publisher = "Elsevier Ltd.",

number = "6",

}

TY - JOUR

T1 - Combining immunomodulators and antivirals for COVID-19 – Authors' reply

AU - Almansa, Raquel

AU - Tedim, Ana P.

AU - de la Fuente, Amanda

AU - Eiros, Jose María

AU - Kelvin, David J.

AU - Torres, Antoni

AU - Bermejo-Martin, Jesus F.

N1 - Funding Information: JFB-M, RA, APT, JME, AT, and DJK have a patent pending (EP20383140.9). AT reports grants from Instituto de Salud Carlos III. DJK reports grants from Canadian Institutes of Health Research, Research Nova Scotia, Atlantic Genome/Genome Canada, Li-Ka Shing Foundation, and Dalhousie Medical Research Foundation. AdlF declares no competing interests.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85107112347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107112347&partnerID=8YFLogxK

U2 - 10.1016/S2666-5247(21)00115-4

DO - 10.1016/S2666-5247(21)00115-4

M3 - Letter

AN - SCOPUS:85107112347

SN - 2666-5247

VL - 2

SP - e234

JO - The Lancet Microbe

JF - The Lancet Microbe

IS - 6

ER -